European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) SARS-CoV-2 Antibody Study Protocol. Covid-19

CompletedOBSERVATIONAL
Enrollment

906

Participants

Timeline

Start Date

October 14, 2020

Primary Completion Date

July 9, 2022

Study Completion Date

July 9, 2022

Conditions
Sars-Cov2 Antibodies in Children and Adolescents Living With HIV
Trial Locations (7)

28007

Hospital General Universitario Gregorio Marañón, Madrid

65012

CBO Perinatal Prevention of AIDS Initiative (PPAI), Odesa

Unknown

Centre Hospitalier Universitaire Saint Pierre, Brussels

"Agia Sophia Children's Hospital of Athens, First Department of Paediatrics & Immunobiology & Vaccinology", Athens

University of Cape Town, Cape Town

08950

Hospital Sant Joan De Déu, Barcelona

WC1E 6BT

University College London, London

All Listed Sponsors
collaborator

Centre Hospitalier Universitaire Saint Pierre

OTHER

collaborator

University of Athens

OTHER

collaborator

University of Cape Town

OTHER

collaborator

Hospital General Universitario Gregorio Marañon

OTHER

collaborator

Hospital Sant Joan de Deu

OTHER

collaborator

Great Ormond Street Hospital for Children NHS Foundation Trust

OTHER

collaborator

Guy's and St Thomas' NHS Foundation Trust

OTHER

collaborator

Northern Care Alliance NHS Group

OTHER

collaborator

University Hospital Birmingham NHS Foundation Trust

OTHER

collaborator

Imperial College Healthcare NHS Trust

OTHER

collaborator

King's College Hospital NHS Trust

OTHER

collaborator

St George's University Hospitals NHS Foundation Trust

OTHER

collaborator

CHIPS+ Cohort

OTHER

collaborator

University College, London

OTHER

lead

PENTA Foundation

NETWORK

NCT04726137 - European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) SARS-CoV-2 Antibody Study Protocol. Covid-19 | Biotech Hunter | Biotech Hunter